Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

dc.contributor.author	Biswal, S.
dc.contributor.author	Borja-Tabora, C.
dc.contributor.author	Vargas, L.M.
dc.contributor.author	Fernando, A.D.
dc.contributor.author	Gunasekera, D.
dc.date.accessioned	2022-09-15T08:54:17Z
dc.date.available	2022-09-15T08:54:17Z
dc.date.issued	2020
dc.identifier.citation	Biswal, S., et al. (2020). Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial. www.thelancet.com Vol 395 May 2, 2020.	en_US
dc.identifier.uri	http://dr.lib.sjp.ac.lk/handle/123456789/12304
dc.language.iso	en	en_US
dc.title	Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial	en_US
dc.type	Article	en_US